Atlas Trials

Fruquintinib Hepatic Impairment Study

Clinical trial NCT05216367 · COMPLETED

Trial details

NCT number
NCT05216367
Sponsor
Hutchmed
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2022-03-11
Primary completion
2022-10-25
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.